EUVIMEDEUVIMED entdecken
Open Access

Lack of clinical change in longitudinal vibration controlled transient elastography among children with cystic fibrosis and poor association with non-invasive biomarkers of liver disease

Wen Ye, Suiyuan Huang, Molly Bozic, Boaz Karmazyn, Roger Harned, Daniel H Leung, Prakash Masand, Adina Alazraki, Simon C Ling, Oscar M Navarro, Nicole Green, Randolph K Otto und 8 weitere

Journal of Cystic Fibrosis · 2026

DOI: 10.1016/j.jcf.2026.04.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2026. Verfasst von Wen Ye und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of Michigan, Ann Arbor, MI. Hauptthemen laut MEDLINE: Elasticity Imaging Techniques, Cystic Fibrosis, Liver Diseases, Liver. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, Cystic Fibrosis Foundation, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Liver stiffness measurement (LSM) has gained interest as a modality to screen for cystic fibrosis hepato-biliary involvement (CFHBI) and monitor for disease progression. Studies of its effectiveness in longitudinal prospective cohorts are lacking. METHODS: The ELASTIC study evaluated LSM by FibroScan® in children with or without CFHBI. Liver ultrasound (US) and clinical data were collected annually. Changes in LSM were assessed for association with US grade and changes in noninvasive biomarkers of liver disease. Additionally, we evaluated intra-individual variation in LSM measurements utilizing the reliable change index. RESULTS: There were 96 participants completed longitudinal assessment by FibroScan® with US and laboratory data available within one-year. Nodular (NOD) and normal (NL) US patterns were significantly associated with decrease in LSM (-5.4% and -4.7% respectively), but within expected variability. No association with LSM was observed among heterogenous (HTG) or homogenous (HMG) US patterns. Reliable change index showed large intra-individual variation between FibroScan® examinations with a decrement of 48% through an increment of 93% being within the normal range of expected variation. Changes in LSM were associated (p < 0.001) with clinical variables including GGT (r= 0.64), spleen size z-score (r=0.42), platelets (r=-0.38), and APRI (r=0.34). CONCLUSION: There is considerable intra-individual variation of LSM by FibroScan® among children with or without CFHBI. We were unable to detect incremental changes in LSM in CFHBI. Significant association between changes in LSM and biomarkers of liver disease were observed. Further exploration is required to determine the clinical utility of LSM in the assessment of CFHBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Elasticity Imaging TechniquesCystic FibrosisLiver DiseasesLiverHumansMaleFemaleChildBiomarkersLongitudinal StudiesAdolescentProspective StudiesDisease ProgressionChild, Preschool

Stichwörter der Autor:innen

Controlled attenuation parameterCystic fibrosisCystic fibrosis associated liver diseaseCystic fibrosis hepato-biliary involvementLiver stiffness measurementTransient elastography

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Biostatistics, University of Michigan, Ann Arbor, MI.
  • Pediatric Gastroenterology, Hepatology and Nutrition, Riley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Pediatric Radiology, Riley Hospital for Children, Indianapolis, IN, USA.
  • Division of Pediatric Radiology, Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, CO, USA.
  • Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Hospital, Department of Pediatrics, Baylor College of Medicine, Houston TX, USA.
  • Division of Radiology, Texas Children's Hospital, Houston, TX, USA.

Förderung

  • NIDDK NIH HHS
  • Cystic Fibrosis Foundation
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Ye, W., Huang, S., Bozic, M., Karmazyn, B., Harned, R., Leung, D. H., Masand, P., Alazraki, A., Ling, S. C., Navarro, O. M., Green, N., Otto, R. K., Palermo, J. J., Towbin, A. J., Alonso, E. M., Nicholas, J. L., Magee, J. C., Narkewicz, M. R., Freeman, A. J., & CFLD-NET (2026). Lack of clinical change in longitudinal vibration controlled transient elastography among children with cystic fibrosis and poor association with non-invasive biomarkers of liver disease. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2026.04.002

Vancouver

Ye W, Huang S, Bozic M, Karmazyn B, Harned R, Leung DH, et al. Lack of clinical change in longitudinal vibration controlled transient elastography among children with cystic fibrosis and poor association with non-invasive biomarkers of liver disease. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2026.04.002

BibTeX
@article{Ye2026,
  author = {Ye, Wen and Huang, Suiyuan and Bozic, Molly and Karmazyn, Boaz and Harned, Roger and Leung, Daniel H and Masand, Prakash and Alazraki, Adina and Ling, Simon C and Navarro, Oscar M and Green, Nicole and Otto, Randolph K and Palermo, Joseph J and Towbin, Alexander J and Alonso, Estella M and Nicholas, Jennifer L and Magee, John C and Narkewicz, Michael R and Freeman, A Jay and CFLD-NET, CFLD-NET},
  title = {Lack of clinical change in longitudinal vibration controlled transient elastography among children with cystic fibrosis and poor association with non-invasive biomarkers of liver disease},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  doi = {10.1016/j.jcf.2026.04.002}
}
Kostenlos starten →